129 related articles for article (PubMed ID: 8213970)
1. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
Ulbig MR; Riordan-Eva P; Holz FG; Rees HC; Hamilton PA
Am J Ophthalmol; 1993 Oct; 116(4):410-3. PubMed ID: 8213970
[TBL] [Abstract][Full Text] [Related]
2. [Ocular impairment during type II membranoproliferative glomerulonephritis].
Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
[TBL] [Abstract][Full Text] [Related]
3. High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2.
Adhi M; Read SP; Liu JJ; Fujimoto JG; Duker JS
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):614-7. PubMed ID: 25423645
[TBL] [Abstract][Full Text] [Related]
4. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression.
Abdelsalam A; Del Priore L; Zarbin MA
Surv Ophthalmol; 1999; 44(1):1-29. PubMed ID: 10466585
[TBL] [Abstract][Full Text] [Related]
5. Posterior segment changes in membranoproliferative glomerulonephritis.
Kim DD; Mieler WF; Wolf MD
Am J Ophthalmol; 1992 Nov; 114(5):593-9. PubMed ID: 1443022
[TBL] [Abstract][Full Text] [Related]
6. Fundus changes in chronic membranoproliferative glomerulonephritis type II.
Michielsen B; Leys A; Van Damme B; Missotten L
Doc Ophthalmol; 1990-1991; 76(3):219-29. PubMed ID: 2103524
[TBL] [Abstract][Full Text] [Related]
7. Fundus changes in type III membranoproliferative glomerulonephritis: a case report.
Takei M; Obana A; Inomata T; Tanaka T; Shiang T; Bae Y; Takemura T; Murakami A
BMC Ophthalmol; 2018 Mar; 18(1):72. PubMed ID: 29510686
[TBL] [Abstract][Full Text] [Related]
8. Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.
Kheir V; Dirani A; Halfon M; Venetz JP; Halabi G; Guex-Crosier Y
BMC Ophthalmol; 2017 Nov; 17(1):207. PubMed ID: 29166869
[TBL] [Abstract][Full Text] [Related]
9. A long history of dense deposit disease.
Cunningham A; Kotagiri A
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):228. PubMed ID: 30255792
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography of fundus abnormalities associated with type II membranoproliferative glomerulonephritis.
Batioğlu F; Müftüoğlu O; Atmaca L
Retina; 2003 Apr; 23(2):261-2. PubMed ID: 12707615
[No Abstract] [Full Text] [Related]
11. [The Bruch membrane and choroid. Angiography and functional characteristics in age-related changes].
Pauleikhoff D; Chen J; Bird AC; Wessing A
Ophthalmologe; 1992 Feb; 89(1):39-44. PubMed ID: 1581691
[TBL] [Abstract][Full Text] [Related]
12. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II.
Leys A; Michielsen B; Leys M; Vanrenterghem Y; Missotten L; Van Damme B
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):499-504. PubMed ID: 2265764
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.
O'Brien C; Duvall-Young J; Brown M; Short C; Bone M
Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672
[TBL] [Abstract][Full Text] [Related]
14. Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II).
Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
Eur J Ophthalmol; 1991; 1(1):17-22. PubMed ID: 1821193
[TBL] [Abstract][Full Text] [Related]
15. Retinal function abnormalities in membranoproliferative glomerulonephritis type II.
Kim RY; Faktorovich EG; Kuo CY; Olson JL
Am J Ophthalmol; 1997 May; 123(5):619-28. PubMed ID: 9152067
[TBL] [Abstract][Full Text] [Related]
16. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.
Duvall-Young J; Short CD; Raines MF; Gokal R; Lawler W
Br J Ophthalmol; 1989 Nov; 73(11):900-6. PubMed ID: 2605144
[TBL] [Abstract][Full Text] [Related]
17. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.
Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):406-10. PubMed ID: 1937071
[TBL] [Abstract][Full Text] [Related]
18. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.
Duvall-Young J; MacDonald MK; McKechnie NM
Br J Ophthalmol; 1989 Apr; 73(4):297-302. PubMed ID: 2713310
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic multiple serous detachments of the retinal pigment epithelium followed by bilateral central serous chorioretinopathy: a case report.
Bandello F; Incorvaia C; Parmeggiani F; Sebastiani A
Ophthalmologica; 2000; 214(5):362-7. PubMed ID: 10965253
[TBL] [Abstract][Full Text] [Related]
20. [Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization].
Karampelas M; Kopsachilis N; Chang JH; Pal B
Ophthalmologe; 2012 Aug; 109(8):791-3. PubMed ID: 22911355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
